Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology
REVeRT, a dual vector approach based on mRNA trans-splicing, enables delivery of genes larger than the usual AAV packagi…
REVeRT, a dual vector approach based on mRNA trans-splicing, enables delivery of genes larger than the usual AAV packagi…
Efficient transfer of larger gene via ViGeneron’s proprietary technology platforms REVeRT and vgAAV ViGeneron advances i…
Osisko Gold Royalties Ltd ("Osisko Royalties" - https://www.commodity-tv.com/...) (OR: TSX & NYSE) and Osisko Developme…
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral thera…
Masern sollten längst ausgerottet sein – stattdessen nehmen sie wieder zu. In den ersten sechs Monaten 2019 wurden weltw…
Lophius Biosciences GmbH today announced the publication of a peer-reviewed scientific paper covering the company’s CE-m…
Xenikos B.V., fokussiert auf die Entwicklung innovativer Immuntherapien zur Behandlung von Patienten, die an schwerwiege…
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft mat…
Lophius Biosciences GmbH and Mediphos Medical Supplies B.V. today announced their distribution partnership for the in vi…
Lophius Biosciences GmbH today announced the launch of the next generation of its in vitro diagnostic test T-Track® CMV…